Armand, Philippe http://orcid.org/0000-0001-6098-1603
Lesokhin, Alexander
Borrello, Ivan
Timmerman, John
Gutierrez, Martin
Zhu, Lili
Popa McKiver, Mihaela
Ansell, Stephen M. http://orcid.org/0000-0003-1244-6758
Funding for this research was provided by:
Leukemia and Lymphoma Society
Bristol-Myers Squibb
Memorial Sloan-Kettering Cancer Center (P30 CA008748)
Article History
Received: 11 February 2020
Revised: 5 June 2020
Accepted: 16 June 2020
First Online: 29 June 2020
Compliance with ethical standards
:
: PA: Paid consultancy from Merck, Bristol Myers Squibb, Pfizer, Affimed, Adaptive, Infinity, ADC Therapeutics, Celgene, Morphosys, Daiichi Sankyo and Miltenyi; research funding (inst) from Adaptive, Affimed, Bristol Myers Squibb, Merck, Otsuka, Roche, Sigma Tau, Tensha, Genentech and IGM; honoraria from Bristol Myers Squibb and Merck. AL: Research funding: Bristol Myers Squibb, Genentech, Janssen, Serametrix; honoraria: Bristol Myers Squibb, Janssen, Novartis, Syndax. IB: Honoraria: Celgene; speakers bureau: Celgene, Onyx; research funding: Bristol Myers Squibb, Celgene. JT: Paid consultancy from Bristol Myers Squibb, Celgene, Celldex therapeutics, Immune Design, and Partner Therapeutics and research funding from Bristol Myers Squibb, Kite Pharma, Merck, and Spectrum. MG: Bayer Health Care Pharmaceuticals, Inc.: Other: Traveling and Lodging- Food and Beverage. E.R. Squibb & Sons, LLC (Bristol Myers Squibb): Consultancy, Other: Travel and Lodging. Incyte Corporation: Consultancy. Pfizer Inc: Consultancy. Merck Sharp & Dohme Corporation: Consultancy, Other: Travel and Lodging. Pharmacyclics LLC, An AbbVie Company: Other: Food and Beverage. LZ: Employment, stock ownership: Bristol Myers Squibb. MPM: Employment, stock ownership: Bristol Myers Squibb. SMA: Research funding (inst) from Bristol Myers Squibb, Affimed, Regeneron, Pfizer, Seattle Genetics, Takeda and AI Therapeutics.